Sinergi Inti Plastindo Tbk. vs Merck Tbk. — how do they compare? Sinergi Inti Plastindo Tbk. trades at Rp130 (market cap 142.07B, 16.34M 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 24.6K 24h volume). The key difference: Merck Tbk. is far larger — about 12× Sinergi Inti Plastindo Tbk.'s market cap, and Sinergi Inti Plastindo Tbk. is more actively traded (16.34M versus 24.6K). Which is the better fit depends on your goals.
| ESIP | MERK | |
|---|---|---|
Market Cap | 142.07B | 1.7T |
Volume | 16.34M | 24.6K |
Lot | 163.4K | 246 |
Turnover | 2.11B | 94.38M |
Average Price | 129.38 | 3,836.59 |
Value | 2.11B | 94.38M |
Indicative Equilibrium Price | 128 | 3,850 |
Indicative Equilibrium Volume | 193.3K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Sinergi Inti Plastindo Tbk (the”Company”) was established based on the notarial deed No.123 dated October 12, 2001 from Dr. Irawan Soerodjo, S.H., M.Si., Notary in Jakarta. PT Tanindo Omega Pasifik is a ultimate parent entity.
Read more on ESIP →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →